114 related articles for article (PubMed ID: 7522005)
1. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.
Wikstrand CJ; Fredman P; McLendon RR; Svennerholm L; Bigner DD
Mol Chem Neuropathol; 1994; 21(2-3):129-38. PubMed ID: 7522005
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
Wikstrand CJ; He XM; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882
[TBL] [Abstract][Full Text] [Related]
3. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736
[TBL] [Abstract][Full Text] [Related]
4. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD
Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092
[TBL] [Abstract][Full Text] [Related]
5. In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.
Fredman P; Wikstrand CJ; Månsson JE; Reifenberger G; Bigner SH; Rasheed A; Svennerholm L; Bigner DD
Glycoconj J; 1996 Jun; 13(3):391-9. PubMed ID: 8781970
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors.
Fredman P
Prog Brain Res; 1994; 101():225-40. PubMed ID: 8029453
[TBL] [Abstract][Full Text] [Related]
7. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
von Holst H; Nygren C; Boström K; Collins VP; Fredman P
Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to malignant human gliomas.
Wikstrand CJ; Fredman P; Svennerholm L; Humphrey PA; Bigner SH; Bigner DD
Mol Chem Neuropathol; 1992 Oct; 17(2):137-46. PubMed ID: 1384525
[TBL] [Abstract][Full Text] [Related]
9. Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.
Piao H; Kuan CT; Chandramohan V; Keir ST; Pegram CN; Bao X; Månsson JE; Pastan IH; Bigner DD
MAbs; 2013; 5(5):748-62. PubMed ID: 23924792
[TBL] [Abstract][Full Text] [Related]
10. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P
Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928
[TBL] [Abstract][Full Text] [Related]
11. Chemical, metabolic and immunological characterization of gangliosides of human glioma cells.
Maeda Y; Yamaki T; Yoshikawa J; Tatewaki K; Piao H; Yu H; Ibayashi Y; Hashi K
Cancer Biochem Biophys; 1998 Nov; 16(4):313-32. PubMed ID: 9925280
[TBL] [Abstract][Full Text] [Related]
12. GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.
Kato Y; Kuan CT; Chang J; Kaneko MK; Ayriss J; Piao H; Chandramohan V; Pegram C; McLendon RE; Fredman P; Månsson JE; Bigner DD
Biochem Biophys Res Commun; 2010 Jan; 391(1):750-5. PubMed ID: 19944071
[TBL] [Abstract][Full Text] [Related]
13. Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice.
Ecsedy JA; Holthaus KA; Yohe HC; Seyfried TN
J Neurochem; 1999 Jul; 73(1):254-9. PubMed ID: 10386978
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside mapping of a human medulloblastoma xenograft.
Gottfries J; Mansson JE; Fredman P; Wikstrand CJ; Friedman HS; Bigner DD; Svennerholm L
Acta Neuropathol; 1989; 77(3):283-8. PubMed ID: 2922991
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats.
Fredman P; Månsson JE; Bigner SH; Wikstrand CJ; Bigner DD; Svennerholm L
Biochim Biophys Acta; 1990 Aug; 1045(3):239-44. PubMed ID: 2386796
[TBL] [Abstract][Full Text] [Related]
17. Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.
Fredman P; von Holst H; Collins VP; Granholm L; Svennerholm L
J Neurochem; 1988 Mar; 50(3):912-9. PubMed ID: 3339365
[TBL] [Abstract][Full Text] [Related]
18. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
Longee DC; Wikstrand CJ; Månsson JE; He X; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
Acta Neuropathol; 1991; 82(1):45-54. PubMed ID: 1659106
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of cultured human glioma cells by beta-interferon is not dependent on changes in ganglioside composition.
Yates AJ; Markowitz DL; Stephens RE; Pearl DK; Whisler RL
J Neuropathol Exp Neurol; 1988 Mar; 47(2):119-27. PubMed ID: 3339370
[TBL] [Abstract][Full Text] [Related]
20. Shedding of gangliosides by human medulloblastoma cells.
Chang F; Li R; Ladisch S
Exp Cell Res; 1997 Aug; 234(2):341-6. PubMed ID: 9260903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
